NCT01752257View on ClinicalTrials.gov

EF5 in Melanoma Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Melanoma
Interventions
DRUG

EF5 Hypoxia

EF5 is a dye used to measure hypoxia

Trial Locations (1)

27705

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

Varian, a Siemens Healthineers Company

INDUSTRY

lead

Douglas Tyler

OTHER

NCT01752257 - EF5 in Melanoma Patients | Biotech Hunter | Biotech Hunter